- Home
- AEHL vs SONN Comparison
AEHL vs SONN Comparison
Compare AEHL & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHL
- SONN
- Stock Information
- Founded
- AEHL 1993
- SONN N/A
- Country
- AEHL United States
- SONN United States
- Employees
- AEHL N/A
- SONN N/A
- Industry
- AEHL Building Materials
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- AEHL Industrials
- SONN Health Care
- Exchange
- AEHL Nasdaq
- SONN Nasdaq
- Market Cap
- AEHL 4.0M
- SONN 3.3M
- IPO Year
- AEHL 2007
- SONN N/A
- Fundamental
- Price
- AEHL $0.31
- SONN $3.02
- Analyst Decision
- AEHL
- SONN Strong Buy
- Analyst Count
- AEHL 0
- SONN 3
- Target Price
- AEHL N/A
- SONN $117.33
- AVG Volume (30 Days)
- AEHL 1.4M
- SONN 1.3M
- Earning Date
- AEHL 09-30-2024
- SONN 12-12-2024
- Dividend Yield
- AEHL N/A
- SONN N/A
- EPS Growth
- AEHL N/A
- SONN N/A
- EPS
- AEHL N/A
- SONN N/A
- Revenue
- AEHL $69,082,235.00
- SONN $55,881.00
- Revenue This Year
- AEHL N/A
- SONN N/A
- Revenue Next Year
- AEHL N/A
- SONN N/A
- P/E Ratio
- AEHL N/A
- SONN N/A
- Revenue Growth
- AEHL 1.87
- SONN N/A
- 52 Week Low
- AEHL $0.23
- SONN $2.85
- 52 Week High
- AEHL $6.41
- SONN $18.72
- Technical
- Relative Strength Index (RSI)
- AEHL 28.96
- SONN 25.74
- Support Level
- AEHL $0.27
- SONN $2.85
- Resistance Level
- AEHL $0.33
- SONN $10.02
- Average True Range (ATR)
- AEHL 0.05
- SONN 0.81
- MACD
- AEHL 0.03
- SONN -0.11
- Stochastic Oscillator
- AEHL 47.25
- SONN 2.37
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd is a manufacturer of ceramic tiles in China. Its ceramic tiles are used for exterior siding, interior flooring, and design in residential and commercial buildings. The company's products are Porcelain, Glazed, Glazed porcelain, Rustic, and polished glazed tiles. The Company operates in the manufacturing and sale of medium to high-end ceramic tiles and providing business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.